Literature DB >> 2514185

Antimicrobial peptides, isolated from horseshoe crab hemocytes, tachyplesin II, and polyphemusins I and II: chemical structures and biological activity.

T Miyata1, F Tokunaga, T Yoneya, K Yoshikawa, S Iwanaga, M Niwa, T Takao, Y Shimonishi.   

Abstract

Tachyplesin is an antimicrobial peptide recently found in the acid extract of hemocytes from the Japanese horseshoe crab (Tachypleus tridentatus) [Nakamura, T. et al. (1988) J. Biol. Chem. 263, 16709-16713]. In our continuing studies on the peptide, we have found an isopeptide, tachyplesin II, and also polyphemusins I and II in hemocytes of the American horseshoe crab (Limulus polyphemus). The complete primary structures of these peptides, which are very similar to that of the previously isolated peptide, now named tachyplesin I, were determined to be as follows: (Table: see text). The isopeptide, tachyplesin II, consists of 17 residues with a COOH-terminal arginine alpha-amide. On the other hand, both polyphemusins I and II were found to contain 18 residues due to an additional Arg residue at the NH2-terminal end as well as a COOH-terminal arginine alpha-amide. The disulfide linkages for polyphemusin I consisted of two bridges between Cys-4 and Cys-17 and between Cys-8 and Cys-13, which was identical to in the case of tachyplesin I. Moreover, all of these peptides inhibited the growth of not only Gram-negative and -positive bacteria but also fungi, such as Candida albicans M9. Furthermore, complex formation between these peptides and bacterial lipopolysaccharides was also observed in a double diffusion test. These results suggest that tachyplesins and polyphemusins are probably located in the hemocyte membrane, where they act on antimicrobial peptides as a self-defense mechanism in the horseshoe crab against invading microorganisms.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2514185     DOI: 10.1093/oxfordjournals.jbchem.a122913

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  43 in total

Review 1.  Agents that increase the permeability of the outer membrane.

Authors:  M Vaara
Journal:  Microbiol Rev       Date:  1992-09

Review 2.  Antimicrobial peptides from marine invertebrates.

Authors:  J Andy Tincu; Steven W Taylor
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

3.  Mechanisms of antibacterial action of tachyplesins and polyphemusins, a group of antimicrobial peptides isolated from horseshoe crab hemocytes.

Authors:  M Ohta; H Ito; K Masuda; S Tanaka; Y Arakawa; R Wacharotayankun; N Kato
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

Review 4.  Designing antimicrobial peptides: form follows function.

Authors:  Christopher D Fjell; Jan A Hiss; Robert E W Hancock; Gisbert Schneider
Journal:  Nat Rev Drug Discov       Date:  2011-12-16       Impact factor: 84.694

Review 5.  Role of Marine Natural Products in the Genesis of Antiviral Agents.

Authors:  Vedanjali Gogineni; Raymond F Schinazi; Mark T Hamann
Journal:  Chem Rev       Date:  2015-08-28       Impact factor: 60.622

6.  The antimicrobial peptide polyphemusin localizes to the cytoplasm of Escherichia coli following treatment.

Authors:  Jon-Paul S Powers; Morgan M Martin; Danika L Goosney; Robert E W Hancock
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

7.  Solution structure and interaction of the antimicrobial polyphemusins with lipid membranes.

Authors:  Jon-Paul S Powers; Anmin Tan; Ayyalusamy Ramamoorthy; Robert E W Hancock
Journal:  Biochemistry       Date:  2005-11-29       Impact factor: 3.162

8.  Implicit Membrane Investigation of the Stability of Antimicrobial Peptide β-Barrels and Arcs.

Authors:  Richard B Lipkin; Themis Lazaridis
Journal:  J Membr Biol       Date:  2014-11-28       Impact factor: 1.843

Review 9.  Conventional and unconventional antimicrobials from fish, marine invertebrates and micro-algae.

Authors:  Valerie J Smith; Andrew P Desbois; Elisabeth A Dyrynda
Journal:  Mar Drugs       Date:  2010-04-14       Impact factor: 5.118

10.  Exploratory studies on development of the chemokine receptor CXCR4 antagonists toward downsizing.

Authors:  Hirokazu Tamamura; Hiroshi Tsutsumi; Wataru Nomura; Nobutaka Fujii
Journal:  Perspect Medicin Chem       Date:  2008-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.